Human Molecular Genetics, 2002, Vol. 11, No. 5 515-523
© 2002 Oxford University Press
Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy
1Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, 208 Bluemle Life Sciences Building, 233 S. 10th Street, Philadelphia, PA 19107, USA, 2Neuroscience Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, PA, USA and 3Department of Radiation and Stress Cell Biology, University of Groningen, Groningen, The Netherlands
Spinal and bulbar muscular atrophy (SBMA) is one of a growing number of neurodegenerative diseases caused by a polyglutamine-encoding CAG trinucleotide repeat expansion, and is caused by an expansion within exon 1 of the androgen receptor (AR) gene. The family of polyglutamine diseases is characterized by the presence of ubiquitinated, intranuclear inclusions associated with molecular chaperones and 26S proteasome components, although the role of these inclusions in the pathogenesis of polyglutamine diseases remains unclear. The over-expression of molecular chaperones of the Hsp70 and Hsp40 families has been shown to modulate inclusion frequency and cellular toxicity. We developed a cell culture system which enables the quantitative analysis of the effects of molecular chaperones on the biochemical properties of an expanded repeat AR. Using this approach, we demonstrate that Hsp70 and its co-chaperone Hsp40 not only increase expanded repeat AR solubility, but function to enhance the degradation of expanded repeat AR through the proteasome. Furthermore, our studies indicate that these molecular chaperones significantly decrease the half-life of an expanded repeat AR. Molecular chaperone enhancement of protein degradation points to the modulation of molecular chaperones as a potential therapeutic target for polyglutamine diseases.
+ To whom correspondence should be addressed. Tel: +1 215 503 4907; Fax: +1 215 923 9162; Email: diane.merry@mail.tju.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. L. Montie, M. S. Cho, L. Holder, Y. Liu, A. S. Tsvetkov, S. Finkbeiner, and D. E. Merry Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy Hum. Mol. Genet., June 1, 2009; 18(11): 1937 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tokui, H. Adachi, M. Waza, M. Katsuno, M. Minamiyama, H. Doi, K. Tanaka, J. Hamazaki, S. Murata, F. Tanaka, et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse Hum. Mol. Genet., March 1, 2009; 18(5): 898 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Garyali, P. Siwach, P. K. Singh, R. Puri, S. Mittal, S. Sengupta, R. Parihar, and S. Ganesh The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system Hum. Mol. Genet., February 15, 2009; 18(4): 688 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morishima, A. M. Wang, Z. Yu, W. B. Pratt, Y. Osawa, and A. P. Lieberman CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins Hum. Mol. Genet., December 15, 2008; 17(24): 3942 - 3952. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mishra, P. Dikshit, S. Purkayastha, J. Sharma, N. Nukina, and N. R. Jana E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity J. Biol. Chem., March 21, 2008; 283(12): 7648 - 7656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Niwa, S.-i. Yamada, S. Ishigaki, J. Sone, M. Takahashi, M. Katsuno, F. Tanaka, M. Doyu, and G. Sobue Disulfide Bond Mediates Aggregation, Toxicity, and Ubiquitylation of Familial Amyotrophic Lateral Sclerosis-linked Mutant SOD1 J. Biol. Chem., September 21, 2007; 282(38): 28087 - 28095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model J. Neurosci., May 9, 2007; 27(19): 5115 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Yamada, J.-i. Niwa, S. Ishigaki, M. Takahashi, T. Ito, J. Sone, M. Doyu, and G. Sobue Archaeal Proteasomes Effectively Degrade Aggregation-prone Proteins and Reduce Cellular Toxicities in Mammalian Cells J. Biol. Chem., August 18, 2006; 281(33): 23842 - 23851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katsuno, C. Sang, H. Adachi, M. Minamiyama, M. Waza, F. Tanaka, M. Doyu, and G. Sobue Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease PNAS, November 15, 2005; 102(46): 16801 - 16806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lee, J. M. Choi, C. Lee, K. J. Yi, and Y. Cho Structure of a peptide:N-glycanase-Rad23 complex: Insight into the deglycosylation for denatured glycoproteins PNAS, June 28, 2005; 102(26): 9144 - 9149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carra, M. Sivilotti, A. T. Chavez Zobel, H. Lambert, and J. Landry HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells Hum. Mol. Genet., June 15, 2005; 14(12): 1659 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, Z. Yu, N. Dadgar, S. Varambally, J. Yu, A. M. Chinnaiyan, and A. P. Lieberman The Unfolded Protein Response Modulates Toxicity of the Expanded Glutamine Androgen Receptor J. Biol. Chem., June 3, 2005; 280(22): 21264 - 21271. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice J. Biol. Chem., December 31, 2004; 279(53): 55969 - 55977. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hay, K. Sathasivam, S. Tobaben, B. Stahl, M. Marber, R. Mestril, A. Mahal, D. L. Smith, B. Woodman, and G. P. Bates Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach Hum. Mol. Genet., July 1, 2004; 13(13): 1389 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Klucken, Y. Shin, E. Masliah, B. T. Hyman, and P. J. McLean Hsp70 Reduces {alpha}-Synuclein Aggregation and Toxicity J. Biol. Chem., June 11, 2004; 279(24): 25497 - 25502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wojcik and M. Di Napoli Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy Stroke, June 1, 2004; 35(6): 1506 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abu-Baker, C. Messaed, J. Laganiere, C. Gaspar, B. Brais, and G. A. Rouleau Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy Hum. Mol. Genet., October 16, 2003; 12(20): 2609 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee and C. Chang Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hishikawa, J.-i. Niwa, M. Doyu, T. Ito, S. Ishigaki, Y. Hashizume, and G. Sobue Dorfin Localizes to the Ubiquitylated Inclusions in Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy, and Amyotrophic Lateral Sclerosis Am. J. Pathol., August 1, 2003; 163(2): 609 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mandrusiak, L. K. Beitel, X. Wang, T. C. Scanlon, E. Chevalier-Larsen, D. E. Merry, and M. A. Trifiro Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor Hum. Mol. Genet., July 1, 2003; 12(13): 1497 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Chavez Zobel, A. Loranger, N. Marceau, J. R. Theriault, H. Lambert, and J. Landry Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G {alpha}B-crystallin mutant Hum. Mol. Genet., July 1, 2003; 12(13): 1609 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hauser, Y.-J. Li, S. Takeuchi, R. Walters, M. Noureddine, M. Maready, T. Darden, C. Hulette, E. Martin, E. Hauser, et al. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage Hum. Mol. Genet., March 15, 2003; 12(6): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi, M. Katsuno, M. Minamiyama, C. Sang, G. Pagoulatos, C. Angelidis, M. Kusakabe, A. Yoshiki, Y. Kobayashi, M. Doyu, et al. Heat Shock Protein 70 Chaperone Overexpression Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model by Reducing Nuclear-Localized Mutant Androgen Receptor Protein J. Neurosci., March 15, 2003; 23(6): 2203 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Walcott and D. E. Merry Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy J. Biol. Chem., December 20, 2002; 277(52): 50855 - 50859. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.Y. E. Chan, J. M. Warrick, I. Andriola, D. Merry, and N. M. Bonini Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila Hum. Mol. Genet., November 1, 2002; 11(23): 2895 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G.G.C. Verhoef, K. Lindsten, M. G. Masucci, and N. P. Dantuma Aggregate formation inhibits proteasomal degradation of polyglutamine proteins Hum. Mol. Genet., October 15, 2002; 11(22): 2689 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Lieberman, G. Harmison, A. D. Strand, J. M. Olson, and K. H. Fischbeck Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor Hum. Mol. Genet., August 15, 2002; 11(17): 1967 - 1976. [Abstract] [Full Text] [PDF] |
||||






